Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Declines By 82.5%

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a large decline in short interest in April. As of April 30th, there was short interest totaling 8,769 shares, a decline of 82.5% from the April 15th total of 50,051 shares. Based on an average trading volume of 410,091 shares, the days-to-cover ratio is presently 0.0 days.

Analysts Set New Price Targets

SMMNY has been the subject of several research reports. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a research report on Tuesday, January 13th. Citigroup reaffirmed a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy”.

Siemens Healthineers Stock Performance

Shares of Siemens Healthineers stock traded down $0.03 on Wednesday, reaching $19.86. 168,407 shares of the company were exchanged, compared to its average volume of 170,062. Siemens Healthineers has a 1-year low of $19.54 and a 1-year high of $28.92. The stock’s 50 day moving average price is $21.60 and its 200-day moving average price is $24.23.

Siemens Healthineers (OTCMKTS:SMMNY) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The company had revenue of $6.68 billion for the quarter, compared to analyst estimates of $6.96 billion.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.